Inventor

BY KOLBOT

US12 patents

⚠️ This page may combine multiple inventors who share the name “BY KOLBOT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PRINCIPIA BIOPHARMA INC

5 patents

US11667641B2Jun 6, 2023

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile

PRINCIPIA BIOPHARMA INC0 citations61

US11708370B2Jul 25, 2023

Solid forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

PRINCIPIA BIOPHARMA INC0 citations60

US12281120B2Apr 22, 2025

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile

PRINCIPIA BIOPHARMA INC0 citations59

US12410176B2Sep 9, 2025

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

PRINCIPIA BIOPHARMA INC0 citations56

US11814390B2Nov 14, 2023

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

PRINCIPIA BIOPHARMA INC0 citations56

ONYX THERAPEUTICS INC

4 patents

US9315542B2Apr 19, 2016

ARYX THERAPEUTICS INC

2 patents

US7629466B2Dec 8, 2009

Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders

ARYX THERAPEUTICS INC18 citations89

US7326787B2Feb 5, 2008

Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders

ARYX THERAPEUTICS INC24 citations89

CORVUS PHARMACEUTICALS INC

1 patent

US10654825B2May 19, 2020

Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof

CORVUS PHARMACEUTICALS INC0 citations26

BY KOLBOT

PRINCIPIA BIOPHARMA INC

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile

Solid forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

ONYX THERAPEUTICS INC

Prodrugs of peptide epoxy ketone protease inhibitors

Prodrugs of peptide epoxy ketone protease inhibitors

Prodrugs of peptide epoxy ketone protease inhibitors

Prodrugs of peptide epoxy ketone protease inhibitors

ARYX THERAPEUTICS INC

Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders

Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders

CORVUS PHARMACEUTICALS INC

Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof